Atea Pharmaceuticals, Inc. (AVIR)
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752, an oral purine nucleoside prodrug product candidate, which has completed Phase Ia clinical trial for the treatment of dengue; AT-777, an NS5A inhibitor; AT-787, a co-formulated, oral, pan-genotypic fixed dose combination of AT-527 and AT-777 for the treatment of hepatitis C virous (HCV); and AT-281, a pharmaceutically acceptable salt for the treatment or prevention of an RNA viral infection, including dengue fever, yellow fever, Zika virus, and coronaviridae viral infection, as well as Ruzasvir, an investigational oral, pan genotypic NS5A inhibitor for the treatment of chronic HCV infection. It has a license agreement with Merck & Co, Inc. for development and commercialization of ruzasvir for the treatment of HCV. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
$336.84M
Dr. Jean-Pierre Sommadossi Ph.D.
68.00
Boston, MA
Oct 30, 2020
-1.90
$-2.10
9.14
19.02
0.00%
-1.92
-0.02
0.71
0.00
19.02
-34.48%
-33.24%
Similar stocks (8)
Immix Biopharma, Inc.
IMMX
Elevation Oncology, Inc.
ELEV
Ocean Biomedical, Inc.
OCEA
CNS Pharmaceuticals, Inc.
CNSP
Enveric Biosciences, Inc.
ENVB
Hepion Pharmaceuticals, Inc.
HEPA
CohBar, Inc.
CWBR
eFFECTOR Therapeutics, Inc.
EFTR
ETF Exposure (39)
ETFMG Treatments, Testing and Advancements ETF
GERM
0.66%
iShares Micro-Cap ETF
IWC
0.07482%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.031%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.026%
iShares Biotechnology ETF
IBB
0.02555%
iShares Russell 2000 Value ETF
IWN
0.02094%
Vanguard Russell 2000 Value Index Fund
VTWV
0.02%
iShares Russell 2000 ETF
IWM
0.01087%
John Hancock Multifactor Small Cap ETF
JHSC
0.01%
Fidelity Nasdaq Composite Index ETF
ONEQ
0.01%
Vanguard Horizon Funds - Vanguard Strategic Equity Fund
VSEQX
0.01%
Vanguard Strategic Small-Cap Equity Fund Investor Shares
VSTCX
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
ProShares Ultra Nasdaq Biotechnology
BIB
0.00879441498923453%
Schwab U.S. Small-Cap ETF
SCHA
0.0074793519%
ProShares Ultra Russell2000
UWM
0.00413682086753453%
Dimensional U.S. Targeted Value ETF
DFAT
0.00369205%
Dimensional U.S. Small Cap ETF
DFAS
0.00294501%
ALPS Medical Breakthroughs ETF
SBIO
0.0021%
ProShares UltraPro Russell2000
URTY
0.0020389209937528214%
ProShares Hedge Replication ETF
HDG
0.0017285953749787452%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.001%
Dimensional U.S. Core Equity 2 ETF
DFAC
6.5941e-4%
Schwab U.S. Broad Market ETF
SCHB
5.235689e-4%
iShares Russell 3000 ETF
IWV
4.6e-4%
Dimensional US Core Equity Market ETF
DFAU
3.9087000000000003e-4%
Dimensional U.S. Equity ETF
DFUS
3.3405e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (8)
Immix Biopharma, Inc.
IMMX
Elevation Oncology, Inc.
ELEV
Ocean Biomedical, Inc.
OCEA
CNS Pharmaceuticals, Inc.
CNSP
Enveric Biosciences, Inc.
ENVB
Hepion Pharmaceuticals, Inc.
HEPA
CohBar, Inc.
CWBR
eFFECTOR Therapeutics, Inc.
EFTR
ETF Exposure (39)
ETFMG Treatments, Testing and Advancements ETF
GERM
0.66%
iShares Micro-Cap ETF
IWC
0.07482%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.031%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.026%
iShares Biotechnology ETF
IBB
0.02555%
iShares Russell 2000 Value ETF
IWN
0.02094%
Vanguard Russell 2000 Value Index Fund
VTWV
0.02%
iShares Russell 2000 ETF
IWM
0.01087%
John Hancock Multifactor Small Cap ETF
JHSC
0.01%
Fidelity Nasdaq Composite Index ETF
ONEQ
0.01%
Vanguard Horizon Funds - Vanguard Strategic Equity Fund
VSEQX
0.01%
Vanguard Strategic Small-Cap Equity Fund Investor Shares
VSTCX
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
ProShares Ultra Nasdaq Biotechnology
BIB
0.00879441498923453%
Schwab U.S. Small-Cap ETF
SCHA
0.0074793519%
ProShares Ultra Russell2000
UWM
0.00413682086753453%
Dimensional U.S. Targeted Value ETF
DFAT
0.00369205%
Dimensional U.S. Small Cap ETF
DFAS
0.00294501%
ALPS Medical Breakthroughs ETF
SBIO
0.0021%
ProShares UltraPro Russell2000
URTY
0.0020389209937528214%
ProShares Hedge Replication ETF
HDG
0.0017285953749787452%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
0.001%
Dimensional U.S. Core Equity 2 ETF
DFAC
6.5941e-4%
Schwab U.S. Broad Market ETF
SCHB
5.235689e-4%
iShares Russell 3000 ETF
IWV
4.6e-4%
Dimensional US Core Equity Market ETF
DFAU
3.9087000000000003e-4%
Dimensional U.S. Equity ETF
DFUS
3.3405e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%